ArticleMolecular therapy. Oncology2026
Chimeric antigen receptor T cell targeting CD44E variant in HCC holds therapeutic potential.
Rui Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleMolecular therapy. Oncology2026
Rui Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.